TF and glioblastoma: Furthermore, transferrin is overexpressed on most cancer cells, and transferrin-targeted RES-Ls may be an effective nanomedicine for the treatment of various cancers, including GBM, even though their biodistribution in vivo and ability to cross the BBB remain unknown.